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Abstract
Contagious bovine pleuropneumonia (CBPP), caused by Mycoplasma mycoides subsp. mycoides, is an important
livestock disease in Africa. The current control measures rely on a vaccine with limited efficacy and occasional
severe side effects. Knowledge of the protective arms of immunity involved in this disease will be beneficial for the
development of an improved vaccine. In previous studies on cattle infected with M. mycoides subsp. mycoides,a
correlation was detected between the levels of mycoplasma-specific IFN-g-secreting CD4
+ T lymphocytes and
reduced clinical signs. However, no cause and effect has been established, and the role of such cells and of
protective responses acquired during a primary infection is not known.
We investigated the role of CD4
+ T lymphocytes in CBPP by comparing disease patterns and post mortem findings
between CD4
+ T cell depleted and non-depleted cattle. The depletion was carried out using several injections of
BoCD4 specific murine monoclonal antibody on day 6 after experimental endotracheal infection with the strain
Afadé. All cattle were monitored clinically daily and sacrificed 28-30 days post-infection. Statistically significant but
small differences were observed in the mortality rate between the depleted and non-depleted animals. However,
no differences in clinical parameters (fever, signs of respiratory distress) and pathological lesions were observed,
despite elimination of CD4
+ T cells for more than a week. The slightly higher mortality in the depleted group
suggests a minor role of CD4
+ T cells in control of CBPP.
Introduction
Contagious bovine pleuropneumonia (CBPP) is a live-
stock disease of high economic importance currently
reported in many sub-Saharan African countries. Primary
i n f e c t i o ni nc a t t l ew i t hMycoplasma mycoides subsp.
mycoides causes inflammation of the lung with respira-
tory symptoms and fever, that may progress into a lethal,
generalized acute pleuropneumonia or lead to a chronic
form with milder clinical signs and circumscribed patho-
morphological lesions called sequestra. CBPP can be era-
dicated in countries having efficient veterinary services,
and with the capacity to implement available disease con-
trol measures (test and slaughter policy, animal move-
ment control and the provision of funds to compensate
farmers). However, these measures are not applicable in
m o s tp a r t so fA f r i c a .T h el i v eT 1 / 4 4v a c c i n em o s tc o m -
monly used in Africa induces immunity of short dura-
tion, which makes repeated vaccination campaigns
necessary, and occasionally causes severe side effects.
K n o w l e d g eo ft h en a t u r eo ft h ep r o t e c t i v er e s p o n s e
would greatly assist in the design of a better vaccine.
Although immunization with the live vaccine only con-
fers immunity for up to one year [1], it means that immu-
nological memory can be established. The exact nature of
the protective response has not been determined. In the
past, attempts were carried out to identify the mechan-
isms that trigger immunity towards M. mycoides subsp.
mycoides infection. However, a critical review of past
experiments does not provide clear evidence of the nat-
ure of protective immune responses in CBPP [2-4]. The
existence of acquired immunity after vaccination led
researchers to hypothesize that immune responses may
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may contribute to a reduction in disease severity with
subsequent development of a chronic form of disease.
During primary infection, a correlation was reported
between high numbers of mycoplasma-specific IFN-g-
secreting CD4
+ T lymphocyte subsets and a mild form of
disease [5-8]. The data suggest that such cells, and thus
acquired responses, might be involved in disease control.
In another study no correlation was found between IFN-
g secretion of PBMCs and pathological outcome [9]. It is
possible that differences with respect to the mycoplasma
strain used for infection, the mode of infection and other
environmental factors can alter the host immune
responses and consequently protection. It is also possible
that the number of animals used in the experiments was
not high enough to make unambiguous conclusions, as
pathological signs can vary considerably among indivi-
dual animals. No study has ever demonstrated cause and
effect.
T op r o v i d ee v i d e n c ef o rap r o t e c t i v er o l eo fI F N - g
secreting CD4
+ T cells, the total depletion of CD4
+ T
cells should result in a dramatic increase in disease sever-
ity and mortality during a primary experimental infec-
tion. Even though the CD4
+ T cells consist of several
regulatory subpopulations such as Treg and T helper
cells we do expect a significant effect on disease control
and pathology if a single subpopulation has a major role
in disease control. Since a murine model of CBPP does
not exist, the influence of CD4
+ T cells in CBPP was
investigated in bovine infection. Almost complete elimi-
nation of peripheral T cell subpopulations in cattle has
been achieved using large quantities of BoCD4 or
BoCD8-specific murine monoclonal antibodies [10-12].
In this study, the role of CD4
+ T cells and acquired
responses during a primary infection with M. mycoides
subsp. mycoides was assessed by comparing clinical,
pathological and laboratory parameters in CD4
+ T cell-
depleted and control cattle.
Materials and methods
Animal experiment setup
All protocols of this study were designed and performed in
strict accordance with the Kenyan legislation for animal
experimentation and were approved by the institutional
animal care and use committee (IACUC reference number
2008.08). Since 1993, ILRI has complied voluntarily with
the United Kingdom’s Animals (Scientific Procedures) Act
1986 that contains guidelines and codes of practice for the
housing and care of animals used in scientific procedures.
Twenty castrated Boran cattle (Bos indicus), 14-16
months of age and randomly selected from the ILRI
ranch in Kapiti (CBPP free-region in Kenya), were trans-
ferred to the ILRI campus in Nairobi and kept on pasture
for 2.5 months. After arrival at the campus, all animals
were dewormed twice using levamisole and treated pro-
phylactically against babesiosis and anaplasmosis using
imidocarb. The cattle were re-vaccinated against lumpy
skin disease, anthrax & blackleg (Blanthax vaccine,
Cooper) and twice against foot and mouth disease. All
animals were tested for presence of antibodies against
CBPP, East Coast Fever and trypanosomiasis using
ELISA and found to be negative. One week before experi-
mental infection, all animals were transferred to the ani-
mal biosafety level two (ABSL2) unit. All 20 cattle were
infected on the same day. Cattle were sedated using
0.5 cc of 2% Xylazine solution/per animal and forced in
lateral recumbency on the left side. A bronchial rubber
tube was inserted deeply into the trachea and the infec-
tious inoculum was introduced. Each animal received 50
mL of fresh M. mycoides subsp. mycoides Afadé liquid
culture (2.5 × 10
10 colony forming units per animal)
grown in pH medium [13], followed by 20 mL of a 1.5%
heated agar solution and 30 mL phosphate buffered sal-
ine (PBS). The cattle were allowed to move freely within
the SADF facility. Three veterinarians monitored the
health status of the animals throughout the experiment.
Rectal temperature was measured every morning. Blood
samples for subsequent analysis were taken twice a week
by jugular vein puncture. Animals showing fever for sev-
eral consecutive days, abnormal behavior, breathing dis-
tress, or recumbency and inappetence were euthanized
while the remaining animals were euthanized at 28-30
days post-infection (dpi).
CD4
+ T cells were depleted in 10 of 20 animals at day
6 post-infection (pi) (Table 1). CD4
+ T cell depletion
was achieved by administering five consecutive intrave-
nous injections of BoCD4 specific murine monoclonal
antibody (ILA-11) [10] ascitic fluid starting with 50 μL
followed by 200, 500, 1000 and 8650 μLa ti n t e r v a l so f
one hour. The concentration of the monoclonal anti-
body was 11.8 mg/mL.
Flow cytometry
Peripheral blood mononuclear cells (PBMCs) were har-
vested from blood using standard separation on Ficoll-
Hypaque. Monoclonal antibodies GB21A, IL-A11
(IgG2a) or CC30 (IgG1), IL-A105, MM1A, IL-A24, [14]
were used to detect gδ,C D 4
+,C D 8
+ and CD3
+ Tc e l l s ,
and myeloid cells, respectively. Cells were stained indir-
ectly [10], using a FITC-conjugated anti-mouse IgG or
IgG1 or IgG2a (SouthernBiotech, USA). Flow cytometry
was carried out on a FACSCANTO (Beckton Dickinson,
Erembodegem, Belgium).
When testing peripheral blood for the presence of
lymphocyte subpopulations post depletion, a control
sample with FITC-conjugated second step antibody was
added to monitor possible CD4
+ -antibody (IL-A11)-
coated cells.
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Page 2 of 9Table 1 Summary of post mortem records of cattle after experimental infection with Mycoplasma mycoides subsp. mycoides
Animal
No.
Lung side
affected
Pulmonary
marmorization
Pulmonary
red
hepatization
Pulmonary
gray
hepatization
Pulmonary
necrosis
Pulmonary
sequestra
(size in mm)
Pulmonary
pseudomembrane
Pulmonary
fibrinous
adhesion
Pleural
fluid
(liters)
Resolution
of lesions
Remarks
BD91 † Left +++ + ++ ++ ++
BD93 Left Multifocal 10 ++
BD94 Left Multifocal 20 ++ Renal infarcts
BD96 Left + ++
BD98 † Left + + Multifocal 2-20 ++
BD99 Left ++ 40 ++
BD100 Left Multifocal 40 +++
BD101 Left ++ ++ ++
BD118 † Left ++ +++ ++ ++ +++ ++ 3 Pericarditis
BD119 Left + 10-60 ++
BD92 Left Multifocal ++
BD95 Left & right +++ +++
BD97 † Right +++ +++ + +++ +++ 7 Lung engorgement,
many renal infarcts
BD102 No lesions
BD105 Left Multifocal 20-40 ++
BD106 Left +
BD107 Left +++ Multifocal 20 + ++ Renal infarcts
BD111 Left ++ 30-60 ++ ++
BD115 Left ++ 30 ++
BD116 Left Multifocal ++ Renal infarcts
†-euthanized before 28 dpi, Animals displayed in bold have been depleted.
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9Serology
Complement fixation test (CFT) (CIRAD, France) for
CBPP was performed on all serum samples according to
vendor’s recommendations.
Additionally, sera were tested for antibodies to bovine
herpes virus 1 (BHV-1), bovine respiratory syncytial virus
(BRSV), bovine respiratory parainfluenza-3 (PI-3), bovine
herpes virus 4 (BHV-4) and Coxiella burnetii using the
HerdChek* IBRgB antibody test kit (IDEXX Europe BV,
The Netherlands), Bio-X, BRSV ELISA Kit (Bio-X Diag-
nostics, Belgium), Bio-X Parainfluenza 3 ELISA Kit, (Bio-
X Diagnostics, Belgium), Bio-X BHV-4 ELISA Kit (Bio-X
Diagnostics, Belgium), and CHEKIT Q-Fieber antibody
test kit (IDEXX Europe BV, The Netherlands), respec-
tively according to vendors recommendations.
Microbiology
Lung samples, carpal joint fluid, and pleural fluid speci-
mens taken at necropsy were used for isolation of
M. mycoides subsp. mycoides using modified pH medium
as described before [13]. Lung samples and pleural fluid
were used for screening of Pasteurella and Mannheimia
spp. using standard methods [15].
Statistical analysis
Exact and normal approximation binomial tests were
used to compare the CD4+ T cell depleted group and
the control group using GenStat 12th Edition [16].
P values for differences in fever and complement fixa-
tion test were estimated using a 2-sided 2-sample t-test
comparing average levels between depleted and control
animals at 5% level of significance.
Results
Depletion of CD4
+ T lymphocytes
The level of CD4
+ T cells in peripheral blood was
recorded using flow cytometry throughout the experi-
ment (Figure 1). Administration of monoclonal antibody
ILA-11 resulted in a decrease in the number of peripheral
blood CD4
+ T lymphocytes to below detectable levels.
The number of CD4
+ cells measured by IL-A11 (IgG2a)
or CC30 (IgG1), in combination with isotype-specific sec-
ond step reagents, was always similar (data not shown).
We did not detect CD4
+ antibody (IL-A11) coated cells
the first two days after depletion (data not shown).
Leukocyte populations such as CD8, gδ T cells and mye-
loid cells (Figure 1) were also monitored and found not to
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Figure 1 Average percentage of peripheral lymphocyte subpopulations in cattle during experimental infection. Lymphocyte
subpopulations of CD4
+ (A), CD8
+ (B), gδ
+ (C), and B
+ (D) are displayed. Values were generated using FACS staining of PBMCs from ten CD4
+
T cell depleted (red) and ten control cattle (black) employing monoclonal antibodies specific for corresponding leucocyte markers. Standard
deviations are displayed as bars.
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Page 4 of 9be affected by the depletion experiment, except that their
percentage of the total white blood cell counts increased
due to the disappearance of CD4
+ T lymphocytes.
Clinical observations
Prior to experimental infection no study animals showed
clinical signs of disease while being housed at ILRI in
Nairobi. Immediately after experimental infection, all
animals developed pyrexia (Figure 2), most likely result-
ing from inflammation of the respiratory system due to
inoculum application. Several consecutive days of high
fever (> 39.5°C) were observed in animals from both
groups, about a week after experimental infection.
Despite several peaks observed in a few animals, the
average temperatures did not differ statistically (p =
0.377) between the groups (Figure 2).
All animals were observed for at least one hour per day
to monitor clinical health status, including coughing. The
highest number of animals coughing was observed
between days 12-15 pi, corresponding with the clinical
peak of acute disease in animals (Figure 3). Differences in
breathing distress and the number of animals affected
between the groups were not observed. Four animals
were euthanized because of disease severity, three from
the depleted group (BD91, BD98, and BD119) and one
from the control group (BD97). The percentage of CD4
+
T cells in the latter four animals did not differ from those
of the surviving animals in the same group.
Pathological observations in infected cattle
Animal euthanasia was planned 28-30 dpi (22-24 days
post depletion). One control and two depleted animals
were euthanized on day 16 (BD97, BD91, and BD118)
and another depleted animal (BD98) on day 21 pi. A 1-
sample exact binomial test toe v a l u a t ei fm o r t a l i t yi n
the depleted group was significantly higher than the
control group showed evidence of an increase (p = 0.070).
Post mortem examination showed the presence of
macroscopic lesions in 19 out of 20 animals, confirming
successful experimental infection. The pathological find-
ings are summarized in Table 1. Typology, extension
and lesion severity were variable among the animals
within the groups; no obvious differences between the
two animal groups were observed. The control group
had the only animal without any pathological lung
lesions (BD102).
Mycoplasma isolation and seroconversion
M. mycoides subsp. mycoides w a si s o l a t e df r o ml u n go r
pleural fluid specimens from all infected animals. The
presence of M. mycoides subsp. mycoides was confirmed
using a pathogen specific polymerase chain reaction tar-
geting the lppQ gene [17].
Seroconversion was seen in all animals as shown by
CFT titers (Additional file 1). The average titers mea-
sured between day 13 and day 27 pi did not differ statis-
tically (p = 0.637) between the groups (Figure 4).
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Figure 2 Average body temperatures during experimental infection. Values were generated using daily rectal temperatures from ten CD4
+
T cell depleted (red) and ten control cattle (black). Single standard deviations are displayed as bars.
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Page 5 of 9Diagnosis of pathogens other than M. mycoides subsp.
mycoides
We did not isolate Pasteurella multocida or Mannhei-
mia haemolytica from the lung specimens taken at
necropsy using standard methods. Serological analysis
conducted to investigate the serum response to selected
bovine pathogens (Coxiella burnetii,B R S V ,B H V - 1 ,
BHV-4, PI-3) showed a striking increase in antibody
responses against BHV-4 after experimental infection in
both groups (Table 2).
Discussion
Conflicting opinions for the role of CD4
+ T lymphocytes
in CBPP have been published [5,9]. These are based on
t h ep r e s e n c eo ra b s e n c eo fac o r r e l a t i o nb e t w e e nh i g h
numbers of IFN-g-secreting CD4
+ T cells with mild dis-
ease outcome. As these studies never tested cause and
effect, the aim of this study was to whether M. mycoides
subsp. mycoides-specific CD4
+ T lymphocytes can alter
the course of primary CBPP infection. We compared two
groups of 10 animals, each infected with M. mycoides
subsp. mycoides strain Afadé, one depleted for CD4
+ T
lymphocytes six days pi and the other left untreated.
Clinical parameters such as fever and cough, as well as
post mortem results were recorded. Ten animals per
experimental group were chosen based on statistical con-
siderations and on the assumption that the depleted
group would show a dramatic increase in disease severity
if the CD4
+ T cells were involved in control of the
infection.
A total of 118 mg/animal of the CD4
+-specific monoclo-
nal antibody IL-A11 was administered intravenously in
five increasing doses, to achieve in vivo depletion of CD4
+
T cells. Depletion was successful as confirmed by flow
cytometry showing no CD4
+ cells one day after treatment
in peripheral blood. From previous depletion experiments,
i tw a sa s s u m e dt h a tC D 4
+ T cells were also completely
removed from lymphoid tissues, with exception of the thy-
mus [10]. Naïve CD4
+ cells could be detected in low num-
bers about one week later. The CD4
+ Tc e l ln u m b e r s
remained below 25% of normal throughout the entire
experiment. The data shows that removal of CD4
+ T cells
did not result in clear differences between both groups.
No significant differences were found in fever or the fre-
quency of coughing, both good correlates of clinical CBPP
severity. Additionally, the number and size of lung lesions
did not differ between both groups. The difference
observed in mortality (3/10 versus 1/10), or more correctly
in the number of animals with symptoms that necessitated
euthanasia, was statistically significant (p < 0.07), though
low and could be interpreted as being caused by loss of a
protective response. The numbers demonstrate that the
effect of depletion on mortality is minor.
In order to ensure that the depletion of a T cell popula-
tion did not increase the presence of unrelated pathogens
that could confound the pathology, the presence of a num-
ber of possible bacteria and viruses were monitored before
and after infection. In related mycoplasma, such as
M. bovis [18] and M. hyopneumoniae [19], co-infections
with other pathogens which may contribute to lung
pathology have been observed. Evidence for the presence
of several viruses was detected in our study, however, no
major differences were observed between the two groups.
Interestingly we observed a substantial increase in anti-
body against BHV-4 after infection in both groups, which
suggests an immuno-compromised state in the animals
during clinical CBPP. We speculate that additional patho-
gens may affect CBPP infected animals, which could result
in even more acute clinical symptoms.
One concern is that low numbers of CD4
+ T cells can
mediate a protective function. This is difficult to accept
as low numbers of IFN-g-secreting CD4
+ T cells in acute
animals were not sufficient to prevent acute disease [7].
Another concern is that the role of CD4
+ T cells is com-
pensated by another cell type in treated animals. This
cannot be disproven, but is unlikely. The CD4
+ popula-
tion contains cells that provide regulatory functions, such
as helper and suppressor tasks, which other cell types
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+-depleted and control
animals during experimental infection. Single standard deviations
are displayed as bars.
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Figure 3 Animals recorded coughing during experimental
infection. Values were generated using ten CD4
+ T cell depleted
(red) and ten control cattle (black) observed daily for coughing.
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Page 6 of 9Table 2 Antibody responses of cattle to BHV-1, BHV-4, BRSV, PI-3, and Coxiella burnetii before and after experimental infection with Mycoplasma mycoides
subsp. mycoides
Animal
No.
BHV-1
(pre
infection)
BHV-1
(post
infection)
BRSV
(pre
infection)
BRSV
(post
infection)
PI-3
(pre
infection)
PI-3
(post
infection)
BHV-4
(pre
infection)
BHV-4
(post
infection)
Coxiella
burnetii
(pre infection)
Coxiella burnetii (post
infection)
BD91 † - - + - +++ ++++
BD93 ---- + + +
BD94 - - + - ++++ + +/-
BD96 --+-+ +
BD98 † ---+ + + + / -
BD99 --+-
BD100 ----+
BD101 +++-
BD118
†
---- + +
BD119 ----+
BD92 - - + + ++ +
BD95 - - + ++ + + +
BD97 † ---+ + +
BD102 - - - - +
BD105 +/- - - - ++ ++ ++
BD106 - - - - + + +
BD107 - - - -
BD111 - - - - + +
BD115 - - + + +
BD116 - - - + + + +
BHV-Bovine Herpes Virus; BRSV-Bovine Respiratory Syncytial Virus, PI-3-Parainfluenza 3, †-euthanized before 28 dpi, Animals displayed in bold have been depleted.
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9cannot do. Also, it is unlikely that depletion of peripheral
IFN-g-secreting CD4
+ T cells can trigger a compensating
mechanism, while very low numbers (in acutely infected
cattle) cannot. Furthermore, no compensation in number
of other populations was observed in previous CD4
+
depletion experiments [20].
A reduction in antibodies in the depleted animals
measured by the complement fixation test was not
observed, as would be expected after eliminating a large
portion of T cell help. A reduction in antibody produc-
tion has been observed in previous CD4
+ depletion
experiments in cattle or sheep [20-22]. It is possible that
antibody production had begun prior to the depletion
treatment. This seems unlikely as antibodies were first
detected in blood by day nine and the kinetics of the
antibody responses after that time did not statistically
differ between treated and control groups. Another
explanation is that anti-mycoplasma antibodies might be
produced without T cell help. Such T cell-independent
antibodies have been described in trypanosome infec-
tions, where antibody titres in infected nu/nu mice were
only slightly lower than in normal mice [23]. Myco-
plasma express high amounts of carbohydrate on their
surface [24], which might form repetitive epitopes that
need less T cell help to induce specific antibodies.
One final concern is the timing of depletion. We
depleted six dpi, since previous experimental infections
carried out in Kenya and Namibia suggested that the
peak of clinical symptoms occurred around 2-3 weeks pi
[9,25] and previous depletion experiments suggested
complete elimination of T cells for one to two weeks
after treatment. We succeeded in removing the CD4
+ T
cells before the peak of clinical symptoms, but one can
argue that a protective CD4 response acted prior to the
depletion, or after CD4
+ T cells returned. If the protec-
tive immune response in animals with mild symptoms
of disease was driven by high numbers of IFN-g-secret-
ing CD4
+ T cells, we would not expect such cells to
appear early, as demonstrated in the previous studies
[7,8]. Also, while naïve CD4
+ T cells appeared from the
thymus one week after treatment, one would expect that
a hypothetical, protective CD4
+ T cell response would
be seriously delayed in the depleted animals, leading to
severe disease.
If CD4
+ T cells do not provide the protective response
in a primary infection, what defines whether an animal
develops severe (acute) or a less severe (chronic) disea-
seż Since there is no direct correlation between antibody
titres and disease severity, it is difficult to ascribe a pro-
tective role to high antibody titers. Therefore, we
assume that innate responses may play an important
role. Of course, our data do not rule out a protective
role for CD4
+ T cells in combination with antibody
production after vaccination or during a secondary
infection.
CBPP is a fatal disease particularly in naïve herds
where up to > 30% of animals may die [26], indicating
that during a primary infection the induced responses
are not sufficient or appear too late to adequately con-
trol the disease. Following this reasoning, it is not sur-
prising that acquired responses driven by CD4
+ T cells
only play a minor role in control of primary CBPP infec-
tion as previously speculated [9]. In our opinion future
research efforts towards the identification of protective
immune responses should be focused on an infection
model employing immune animals.
Additional material
Additional file 1: Table S1: Individual serological responses of infected
cattle against Mycoplasma mycoides subsp. mycoides measured by
complement fixation test.
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